Your browser doesn't support javascript.
loading
The combination of astragaloside IV and Panax notoginseng saponins attenuates cerebral ischaemia-reperfusion injury in rats through ferroptosis and inflammation inhibition via activating Nrf2.
Kang, Zhineng; Xiao, Qian; Wang, Linlin; Xiao, Lan; Tang, Biao.
Afiliación
  • Kang Z; Basic Research Center of Integrated Chinese & Western Medicine for Prevention & Treatment of Vascular Diseases, Hunan University of Chinese Medicine, Changsha, China.
  • Xiao Q; Basic Research Center of Integrated Chinese & Western Medicine for Prevention & Treatment of Vascular Diseases, Hunan University of Chinese Medicine, Changsha, China.
  • Wang L; Basic Research Center of Integrated Chinese & Western Medicine for Prevention & Treatment of Vascular Diseases, Hunan University of Chinese Medicine, Changsha, China.
  • Xiao L; Basic Research Center of Integrated Chinese & Western Medicine for Prevention & Treatment of Vascular Diseases, Hunan University of Chinese Medicine, Changsha, China.
  • Tang B; Basic Research Center of Integrated Chinese & Western Medicine for Prevention & Treatment of Vascular Diseases, Hunan University of Chinese Medicine, Changsha, China.
J Pharm Pharmacol ; 75(5): 666-676, 2023 Apr 17.
Article en En | MEDLINE | ID: mdl-36952592
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Saponinas / Daño por Reperfusión / Panax notoginseng / Ferroptosis Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Pharm Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Saponinas / Daño por Reperfusión / Panax notoginseng / Ferroptosis Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Pharm Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido